Advertisement

Topics

Cell Biosciences, Inc Company Profile

16:45 EST 19th November 2017 | BioPortfolio

Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the “post-genomic” age, new tools are in high demand to enable researchers to rapidly develop assays for specific proteins in complex biological samples. High priority needs include specific detection of protein variants, detection of low abundance proteins in small sample volumes and improved quantification and throughput. Cell Biosciences is focused on these priorities to deliver new technology that will be enabling in these areas. We anticipate launch of our first instrument platform in 2006.

Location

1050 Page Mill Road
Palo Alto
California
94303
United States of America

Contact

Phone: 650) 859-1485
Fax: (650) 845-3540
Email: info@cellbiosciences.com


News Articles [1806 Associated News Articles listed on BioPortfolio]

Pascal Biosciences acquires STC technology for B-cell precursor ALL treatment

Canadian drug discovery and development company Pascal Biosciences has executed an exclusive, worldwide licence option agreement with STC.UNM (STC) to purchase a therapeutic monoclonal antibody for B-...

Harmony Biosciences gains US rights to pitolisant; raises $270 million

USA-based Harmony Biosciences, a part of the Paragon Biosciences corporate family, has acquired the exclusive…

Pascal Biosciences options leukemia antibody from STC.UNM

STC.UNM, the tech transfer unit of the University of New Mexico, has granted Pascal Biosciences Inc. a six-month option to license exclusive global rights to its technology surrounding a therapeutic m...

Promethera collaboration to establish breakthrough cell therapy manufacturing platform

Belgian cell therapy company Promethera Biosciences and Japan’s Shibuya Corp have entered into a strategic…

Ricerca Biosciences, LLC Renamed to Concord Biosciences, LLC After Sale of Chemical Development ...

According to Clifford W. Croleyof Main Market Partners and the CEO of Concord Biosciences, "We are very pleased to focus our complete energies Read more...

Caladrius Biosciences to Participate at the 2017 Cell & Gene Meeting on the Mesa

BASKING RIDGE, N.J., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multip...

Apricus Biosciences, Inc.: Apricus Biosciences to Present at the 2017 BIO Investor Forum

SAN DIEGO, 2017-10-10 13:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...

Promethera Biosciences and Shibuya Form Collaboration

Will establish breakthrough cell therapy manufacturing platform

Drugs and Medications [35 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [2731 Associated PubMed Articles listed on BioPortfolio]

A Branching Process Model of Heterogeneous DNA Damages caused by Radiotherapy in in vitro Cell Cultures.

This paper deals with the dynamic modeling and simulation of cell damage heterogeneity and associated mutant cell phenotypes in the therapeutic responses of cancer cell populations submitted to a radi...

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Amnesia and criminal responsibility.

Synthesis and biological evaluation of acyl derivatives of hydroxyflavones as potent antiproliferative agents against drug resistance cell lines.

The synthesis of hydroxyflavone derivatives is described. The acyl derivatives of 3-, 6-, 7-hydroxyflavones (compounds 2, 4, 6, respectively) and chrysin (5,7-dihydroxyflavone, 7) were obtained in hig...

Contents list.

Clinical Trials [5336 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [1234 Associated Companies listed on BioPortfolio]

InQ Biosciences Corporation

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to ce...

InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more...

Cell Biosciences, Inc

Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the “post-genomic” age, new tools are in high demand to enable researchers to rapidly deve...

Cellex Biosciences Incorporated

Cellex Biosciences is dedicated to providing cell processing products and services to meet the needs of human health care and biotechnology markets worldwide with stirred tank cell culturing systems, ...

JRH Biosciences

JRH Biosciences, a CSL Company, is a provider of sera, cell culture media and specialty reagents to the global health care industry.

More Information about "Cell Biosciences, Inc" on BioPortfolio

We have published hundreds of Cell Biosciences, Inc news stories on BioPortfolio along with dozens of Cell Biosciences, Inc Clinical Trials and PubMed Articles about Cell Biosciences, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Biosciences, Inc Companies in our database. You can also find out about relevant Cell Biosciences, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record